18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review.
Soroush Rais-BahramiJason A EfstathiouCatriona M TurnbullStephen B CamperAndy KenwrightDavid M SchusterAndrew F ScarsbrookPublished in: Prostate cancer and prostatic diseases (2021)
18F-Fluciclovine PET/CT shows good performance in patients with recurrent prostate cancer leading to measurable clinical benefits. Careful adherence to recommended imaging protocols may help optimize DR.